Histone deacetylase
From Proteopedia
(Difference between revisions)
(5 intermediate revisions not shown.) | |||
Line 4: | Line 4: | ||
* '''HDAC class I''' are homologous to yeast Rpd3.<br /> | * '''HDAC class I''' are homologous to yeast Rpd3.<br /> | ||
* '''HDAC class II''' are homologous to yeast HdaI.<br /> | * '''HDAC class II''' are homologous to yeast HdaI.<br /> | ||
+ | * '''HDAC class IIa''' lack enzymatic activity<ref>PMID:25244360</ref>. <br /> | ||
* '''HDAC class III''' called '''sirtuin''' - (Silent Information Regulator) (SIRT) are NAD-dependent HDAC. This protein is bifunctional and can act as a deacylase or as mono-ADP-acetyltransferase. <ref>PMID:18249170</ref>.<br /> | * '''HDAC class III''' called '''sirtuin''' - (Silent Information Regulator) (SIRT) are NAD-dependent HDAC. This protein is bifunctional and can act as a deacylase or as mono-ADP-acetyltransferase. <ref>PMID:18249170</ref>.<br /> | ||
+ | * '''HDAC Rpd3''' belongs to class I and is involved in transcriptional repression <ref>PMID:9512514</ref>.<br /> | ||
+ | * '''HDAC Clr (Cryptic Loci Regulator)''' is responsible of deacetylation of Lys residues at the N-terminal of histones .<br /> | ||
+ | |||
+ | For HDAC8 see - [[Histone deacetylase 8 (HDAC8)]].<br /> | ||
For additional details see<br /> | For additional details see<br /> | ||
* [[Understanding of the Recruitment of HDACs by MEF2, Based on Their Structure]]<br /> | * [[Understanding of the Recruitment of HDACs by MEF2, Based on Their Structure]]<br /> | ||
Line 19: | Line 24: | ||
</StructureSection> | </StructureSection> | ||
- | == 3D Structures of histone deacetylase == | ||
- | |||
- | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
- | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | |||
- | *'''HDAC class I''' | ||
- | |||
- | *HDAC1 | ||
- | |||
- | **[[4bkx]] – hHDAC1 + MTA1 – human<br /> | ||
- | **[[3hgq]], [[3hgt]] – hHDAC1 subunit 3<br /> | ||
- | **[[5icn]] – hHDAC1 + MTA1 + peptide<br /> | ||
- | **[[5j8j]] – yHDAC1 residues 457-698 – yeast<br /> | ||
- | |||
- | *HDAC2 | ||
- | |||
- | **[[3max]] – hHDAC2 + amide derivative <br /> | ||
- | **[[4lxz]] – hHDAC2 core domain + SAHA<br /> | ||
- | **[[4ly1]], [[5iwg]], [[5ix0]] – hHDAC2 core domain + inhibitor<br /> | ||
- | |||
- | *HDAC3 | ||
- | |||
- | **[[4a69]] – hHDAC3 + nuclear receptor corepressor 2 + inositol tetraphosphate | ||
- | |||
- | *HDAC8 | ||
- | |||
- | **[[3ew8]], [[3ezp]], [[3ezt]], [[3f06]] – hHDAC8 (mutant)<br /> | ||
- | **[[3sff]], [[3sfh]] – hHDAC8 + inhibitor<br /> | ||
- | **[[1t64]], [[3f0r]], [[5ths]] – hHDAC8 + trichostatin A <br /> | ||
- | **[[5tht]], [[5thu]], [[5thv]], [[5dc5]], [[5d1b]] - hHDAC8 (mutant) + amide derivative<br /> | ||
- | **[[1t67]], [[1w22]], [[1vkg]], [[3f07]] - hHDAC8 + amide derivative<br /> | ||
- | **[[1t69]] - hHDAC8 + SAHA<br /> | ||
- | **[[4qa0]] - hHDAC8 (mutant) + SAHA<br /> | ||
- | **[[5fcw]], [[5fue]] - hHDAC8 + hydroxamate<br /> | ||
- | **[[5vi6]] - hHDAC8 + trapoxin A<br /> | ||
- | **[[4qa1]], [[4qa2]], [[4qa3]], [[4qa4]] - hHDAC8 (mutant) + inhibitor<br /> | ||
- | **[[2v5w]] – hHDAC8 + tripeptide substrate<br /> | ||
- | **[[4qa5]], [[4qa6]], [[4qa7]], [[3ewf]], [[5dc8]], [[5dc7]], [[5dc6]], [[5d1d]], [[5d1c]] - hHDAC8 (mutant) + tetrapeptide substrate<br /> | ||
- | **[[3rqd]] - hHDAC8 + largazole<br /> | ||
- | **[[4rn0]], [[4rn1]], [[4rn2]] - hHDAC8 (mutant) + largazole analog<br /> | ||
- | **[[5bwz]] - hHDAC8 (mutant) + droxinostat<br /> | ||
- | **[[3mz3]] - hHDAC8 (Co) + amide derivative<br /> | ||
- | **[[3mz7]] - hHDAC8 (Co) (mutant) + amide derivative<br /> | ||
- | **[[3mz4]] - hHDAC8 (Mn) (mutant) + amide derivative<br /> | ||
- | **[[3mz6]] - hHDAC8 (Fe) (mutant) + amide derivative<br /> | ||
- | **[[2v5x]] - hHDAC8 (mutant) + octanediamide derivative<br /> | ||
- | **[[4bz5]] – SmHDAC8 – ''Schistosoma mansoni''<br /> | ||
- | **[[4bz7]], [[4bz8]], [[4bz9]], [[4cqf]], [[6hsz]], [[6ht8]], [[6htg]], [[6hth]], [[6hti]], [[6htt]], [[6htz]], [[6hu0]], [[6hu1]], [[6hu2]], [[6hu3]], [[6hsh]], [[6hrq]], [[6hqy]] – SmHDAC8 + inhibitor<br /> | ||
- | **[[6hsk]], [[6hsf]], [[6hsg]] – SmHDAC8 (mutant) + inhibitor<br /> | ||
- | **[[4bz6]], [[6gxw]], [[6gxu]], [[6gxa]], [[6gx3]], [[6fu1]] – SmHDAC8 + SAHA derivative<br /> | ||
- | |||
- | *'''HDAC class IIA''' | ||
- | |||
- | *HDAC4 | ||
- | |||
- | **[[2h8n]] – hHDAC4 N terminal <br /> | ||
- | **[[2o94]] - hHDAC4 N terminal (mutant)<br /> | ||
- | **[[2vqw]] - hHDAC4 catalytic domain (mutant)<br /> | ||
- | **[[2vqj]], [[2vqm]], [[4cbt]], [[5a2s]] – hHDAC4 catalytic domain + inhibitor<br /> | ||
- | **[[6fyz]] - hHDAC4 catalytic domain + SAHA derivative<br /> | ||
- | **[[2vqo]], [[2vqq]], [[2vqv]], [[4cby]] – hHDAC4 catalytic domain (mutant) + inhibitor<br /> | ||
- | **[[5zop]], [[5zoo]] - hHDAC4 catalytic domain (mutant) + SMRT corepressor<br /> | ||
- | |||
- | *HDAC5 | ||
- | |||
- | **[[5uwi]] – hHDAC5 + RAN + RANBP1 + exportin<br /> | ||
- | |||
- | *HDAC7 | ||
- | |||
- | **[[3c0y]] – hHDAC7 catalytic domain<br /> | ||
- | **[[3c0z]] - hHDAC7 catalytic domain + octanedioic acid hydroxyamide phenylamide<br /> | ||
- | **[[3c10]] - hHDAC7 catalytic domain + trichostatin A<br /> | ||
- | **[[3znr]], [[3zns]] - hHDAC7 catalytic domain + inhibitor<br /> | ||
- | |||
- | *HDAC9 | ||
- | |||
- | **[[1tqe]] – mHDAC9 + myocyte-specific enhancer factor + DNA – mouse | ||
- | |||
- | *HDAC | ||
- | |||
- | **[[4a6q]], [[4a90]] - hHDAC subunit SAP18 <br /> | ||
- | **[[2hde]] – hHDAC subunit SAP18 (mutant) – NMR<br /> | ||
- | **[[4a8x]] - hHDAC subunit SAP18 + RNA-binding protein + hook-like<br /> | ||
- | **[[2kdp]] – hHDAC subunit SAP30 – NMR<br /> | ||
- | **[[2ld7]] – hHDAC subunit SAP30 +SIN3A PAH 3 domain – NMR<br /> | ||
- | **[[5ikk]] – HDAC CLR3 – fission yeast<br /> | ||
- | |||
- | *'''HDAC class IIB''' | ||
- | |||
- | *HDAC6 | ||
- | |||
- | **[[3c5k]] – hHDAC6 zinc finger domain<br /> | ||
- | **[[3gv4]] - hHDAC6 zinc finger domain + ubiquitin peptide<br /> | ||
- | **[[3phd]] - hHDAC6 + polyubiquitin<br /> | ||
- | **[[5kh3]], [[5kh7]], [[5kh9]], [[5b8d]], [[6ce6]], [[6ce8]], [[6cea]], [[6cec]], [[6ced]], [[6cee]], [[6cef]], [[5wpb]], [[5wbn]] – hHDAC6 zinc finger + inhibitor<br /> | ||
- | **[[5eem]] – zHDAC6 catalytic domain - zebrafish<br /> | ||
- | **[[6cgp]], [[5wgm]], [[5wgl]], [[5wgi]], [[5wgk]], [[5g0j]], [[5g0i]], [[5g0h]], [[5g0g]], [[5g0f]], [[5efh]], [[5efg]], [[5efb]], [[5ef7]], [[5ef8]], [[5een]], [[5eek]], [[5eef]], [[6mr5]], [[6dvo]], [[6dvn]], [[6dvm]], [[6dvl]], [[6cw8]] – zHDAC6 catalytic domain + inhibitor <br /> | ||
- | **[[5eei]], [[6css]], [[6csr]], [[6csq]], [[6csp]], [[5w5k]] – zHDAC6 catalytic domain + SAHA derivative<br /> | ||
- | **[[5efn]], [[5efk]], [[53fj]] – zHDAC6 catalytic domain (mutant) + peptide <br /> | ||
- | |||
- | |||
- | *'''HDAC class III''' | ||
- | *SIRT1 | ||
- | |||
- | **[[4ig9]] – hSIRT1 + Zn<br /> | ||
- | **[[4i5i]] – hSIRT1 + NAD + indole + Zn<br /> | ||
- | **[[4if6]], [[4kxq]] – hSIRT1 + ADP-ribose + Zn<br /> | ||
- | **[[5btr]] – hSIRT1 + acetyl lysine peptide + resveratol + Zn<br /> | ||
- | **[[4zzh]] – hSIRT1 + activator + Zn<br /> | ||
- | **[[4zzi]] – hSIRT1 + activator + inhibitor + Zn<br /> | ||
- | **[[4zzj]] – hSIRT1 + acetyl lysine peptide + activator + Zn<br /> | ||
- | |||
- | *SIRT2 | ||
- | |||
- | **[[2hjh]] – ySIRT2 + pseudosubstrate + nicotinamide + Zn <br /> | ||
- | **[[4iao]] – ySIRT2 + SIRT4 + ADP-ribose + Zn<br /> | ||
- | **[[1j8f]], [[3zgo]] – hSIRT2 + Zn<br /> | ||
- | **[[5yqo]], [[5yqn]], [[5yqm]], [[5yql]] – hSIRT2 + inhibitor + Zn<br /> | ||
- | **[[5y0z]] – hSIRT2 (mutant) + inhibitor + Zn<br /> | ||
- | **[[3zgv]], [[5d7o]] – hSIRT2+ ADP ribose + Zn<br /> | ||
- | **[[4y6q]] – hSIRT2+ ADP ribose derivative + Zn<br /> | ||
- | **[[4l3o]], [[4y6l]], [[4y6o]] – hSIRT2 + acetyl lysine peptide + Zn<br /> | ||
- | **[[4x3o]], [[4x3p]] – hSIRT2 + myristoyl peptide + Zn<br /> | ||
- | **[[4rmg]], [[5dy4]], [[5dy5]], [[5y5n]], [[5mat]] – hSIRT2 + inhibitor + Zn<br /> | ||
- | **[[5d7p]], [[5d7q]], [[5mar]] – hSIRT2 + inhibitor + ADP-ribose + Zn<br /> | ||
- | **[[4rmh]], [[4rmi]] – hSIRT2 + acetyl lysine peptide + inhibitor + Zn<br /> | ||
- | **[[4r8m]] – hSIRT2 + peptide + tridecanethial + Zn<br /> | ||
- | **[[4rmj]] – hSIRT2 + ADP-ribose + nicotinamide + Zn <br /> | ||
- | **[[5g4c]] – hSIRT2 + carba-NAD + Zn<br/ > | ||
- | **[[5fyq]] – hSIRT2 + RAN AA peptide + Zn<br/ > | ||
- | **[[5dy5]] – hSIRT2 + thiazole derivative + piperazine derivative + Zn<br/ > | ||
- | **[[5dy4]] – hSIRT2 + thiazole derivative + NAD + Zn<br/ > | ||
- | **[[5d7q]], [[5d7p]], [[5d7o]] – hSIRT2 + oxolan derivative + Zn<br/ > | ||
- | |||
- | *SIRT3 | ||
- | |||
- | **[[5d7n]] – hSIRT3 + Zn<br /> | ||
- | **[[3gls]] – hSIRT3 (mutant) + Zn<br /> | ||
- | **[[3glu]], [[5ytk]], [[5y4h]] – hSIRT3 + peptide + Zn<br /> | ||
- | **[[5bwo]], [[5bwn]] – hSIRT3 + palmitoyl H3K9 peptide + Zn<br /> | ||
- | **[[5bwl]] – hSIRT3 + succinyl peptide + Zn<br /> | ||
- | **[[3glr]], [[3glt]], [[4fvt]], [[4bve]], [[6iso]] – hSIRT3 + acetyl lysine peptide + Zn<br /> | ||
- | **[[4hd8]] – hSIRT3 + acetyl lysine peptide + piceatannol + Zn<br /> | ||
- | **[[4fz3]] – hSIRT3 + acetyl lysine peptide + coumarine derivative + Zn<br /> | ||
- | **[[4c78]], [[4c7b]] – hSIRT3 + acetyl lysine peptide + resveratol derivative + Zn<br /> | ||
- | **[[5zgc]], [[5z94]], [[5z93]] – hSIRT3 + histone peptide + Zn<br /> | ||
- | **[[4jsr]], [[4jt8]], [[4jt9]], [[4o8z]] – hSIRT3 + inhibitor + Zn<br /> | ||
- | **[[4gbn5]] – hSIRT3 + inhibitor + carba-NAD + Zn<br/ > | ||
- | **[[4bv3]] – hSIRT3 + inhibitor + NAD + ADP-ribose + Zn<br /> | ||
- | **[[4bvb]], [[4bvh]] – hSIRT3 + inhibitor + ADP-ribose + Zn<br /> | ||
- | **[[4bvf]], [[4bvg]] – hSIRT3 + acetyl lysine peptide + inhibitor + Zn<br /> | ||
- | **[[5h4d]] – hSIRT3 + agonist + NAD + Zn<br/ > | ||
- | |||
- | *SIRT4 | ||
- | |||
- | **[[5ojn]] – hSIRT4 + ADP-ribose + Zn – ''Xenopus tropicalis''<br /> | ||
- | |||
- | *SIRT5 | ||
- | |||
- | **[[2b4y]], [[4bn4]] – hSIRT5 + ADP-ribose + Zn<br /> | ||
- | **[[2nyr]], [[5xhs]] – hSIRT5 + inhibitor + Zn<br /> | ||
- | **[[3rig]], [[3riy]], [[4f4u]] – hSIRT5 + acetyl lysine peptide + Zn<br /> | ||
- | **[[4gic]] – hSIRT5 + acetyl lysine peptide + carba-NAD + Zn<br/ > | ||
- | **[[4f56]] – hSIRT5 + peptide + intermediate + Zn<br /> | ||
- | **[[4hda]] – hSIRT5 + acetyl lysine peptide + resveratrol + Zn<br /> | ||
- | **[[6acp]], [[6aco]], [[6acl]], [[6ace]] – hSIRT5 + succinyl peptide + Zn<br /> | ||
- | **[[4utn]], [[4utr]], [[4utv]], [[4utx]], [[4utz]], [[4uu7]], [[4uu8]], [[4uua]], [[4uub]], [[6flg]], [[6fkz]], [[6fky]] – zSIRT5 + acetyl lysine peptide + inhibitor + Zn <br /> | ||
- | **[[6enx]], [[6eo0]], [[6eqs]] – zSIRT5 + inhibitor + Zn <br /> | ||
- | **[[5ojo]] – zSIRT5 + CPS1 peptide + Zn <br /> | ||
- | |||
- | *SIRT6 | ||
- | |||
- | **[[3k35]] – hSIRT6 + ADP-ribose + Zn<br /> | ||
- | **[[5x16]] – hSIRT6 + oxolan derivative + Zn<br /> | ||
- | **[[6hoy]] – hSIRT6 + ADP-ribose + trichostatin + Zn<br /> | ||
- | **[[3pki]], [[3pkj]] – hSIRT6 (mutant) + ADP-ribose derivative + Zn<br /> | ||
- | **[[3zg6]] – hSIRT6 + acetyl lysine peptide + ADP-ribose + Zn<br /> | ||
- | **[[5mgn]], [[5mfz]], [[5mfp]], [[5mf6]] – hSIRT6 + activator + Zn<br /> | ||
- | **[[5y2f]] – hSIRT6 + peptide activator + Zn<br /> | ||
- | |||
- | *SIRT7 | ||
- | |||
- | **[[5iqz]] – hSIRT7 N-terminal<br /> | ||
- | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
References
- ↑ Joshi P, Greco TM, Guise AJ, Luo Y, Yu F, Nesvizhskii AI, Cristea IM. The functional interactome landscape of the human histone deacetylase family. Mol Syst Biol. 2013;9:672. doi: 10.1038/msb.2013.26. PMID:23752268 doi:http://dx.doi.org/10.1038/msb.2013.26
- ↑ Parra M. Class IIa HDACs FEBS J. 2015 May;282(9):1736-44. PMID:25244360 doi:10.1111/febs.13061
- ↑ Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008 Feb;7(2):104-12. doi: 10.1016/j.cmet.2007.11.006. PMID:18249170 doi:http://dx.doi.org/10.1016/j.cmet.2007.11.006
- ↑ Kadosh D, Struhl K. Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo. Genes Dev. 1998 Mar 15;12(6):797-805. PMID:9512514 doi:10.1101/gad.12.6.797
- ↑ Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001 Dec;1(3):194-202. PMID:11902574 doi:http://dx.doi.org/10.1038/35106079
- ↑ Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol. 2007 Aug;21(8):1745-55. Epub 2007 Apr 24. PMID:17456799 doi:http://dx.doi.org/10.1210/me.2007-0079
- ↑ Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist. 2007 Oct;12(10):1247-52. PMID:17962618 doi:http://dx.doi.org/10.1634/theoncologist.12-10-1247
- ↑ Jin L, Wei W, Jiang Y, Peng H, Cai J, Mao C, Dai H, Choy W, Bemis JE, Jirousek MR, Milne JC, Westphal CH, Perni RB. Crystal structures of human SIRT3 displaying substrate-induced conformational changes. J Biol Chem. 2009 Sep 4;284(36):24394-405. Epub 2009 Jun 16. PMID:19535340 doi:10.1074/jbc.M109.014928